These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 36586223

  • 1. Sodium polystyrene sulfonate versus sodium zirconium cyclosilicate for the treatment of hyperkalemia in the emergency department.
    Hasara S, Dubey J, Amatea J, Finnigan N.
    Am J Emerg Med; 2023 Mar; 65():59-64. PubMed ID: 36586223
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative Efficacy of Sodium Zirconium Cyclosilicate and Sodium Polystyrene Sulfonate for Acute Hyperkalemia: A Retrospective Chart Review.
    Gonzalez J, Nayyar D.
    Hosp Pharm; 2024 Apr; 59(2):159-164. PubMed ID: 38450357
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of Sodium Zirconium Cyclosilicate to Sodium Polystyrene Sulfonate in the Inpatient Management of Acute Hyperkalemia.
    Joyce O, Corpman M.
    J Pharm Pract; 2024 Jun; 37(3):728-735. PubMed ID: 37254518
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sodium zirconium cyclosilicate to increase lithium elimination.
    Heath M, Mann C.
    Am J Emerg Med; 2022 Sep; 59():217.e5-217.e7. PubMed ID: 35811188
    [Abstract] [Full Text] [Related]

  • 10. Emergency Potassium Normalization Treatment Including Sodium Zirconium Cyclosilicate: A Phase II, Randomized, Double-blind, Placebo-controlled Study (ENERGIZE).
    Peacock WF, Rafique Z, Vishnevskiy K, Michelson E, Vishneva E, Zvereva T, Nahra R, Li D, Miller J.
    Acad Emerg Med; 2020 Jun; 27(6):475-486. PubMed ID: 32149451
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety analysis of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on rapid reduction of potassium in moderate to severe hyperkalemia patients with chronic kidney disease without dialysis.
    Fu X, Zhang S, Gao F, Mao N.
    Clin Nephrol; 2024 Oct; 102(4):223-231. PubMed ID: 38994592
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Polysulfonate Resins in Hyperkalemia: A Systematic Review.
    Wong SWS, Zhang G, Norman P, Welihinda H, Wijeratne DT.
    Can J Kidney Health Dis; 2020 Oct; 7():2054358120965838. PubMed ID: 33240515
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial.
    Kosiborod M, Rasmussen HS, Lavin P, Qunibi WY, Spinowitz B, Packham D, Roger SD, Yang A, Lerma E, Singh B.
    JAMA; 2014 Dec 03; 312(21):2223-33. PubMed ID: 25402495
    [Abstract] [Full Text] [Related]

  • 17. Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate.
    Lee J, Moffett BS.
    Pediatr Nephrol; 2016 Nov 03; 31(11):2113-7. PubMed ID: 27215929
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of potassium binders in the treatment of patients with chronic kidney disease and hyperkalemia.
    Dong L, Xu W, Deng Y, Tan J, Qin W.
    Eur J Pharmacol; 2022 Sep 15; 931():175174. PubMed ID: 35964658
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.